|
CNBC'S MOST SHARED
- Rich People With A Death Wish
- Facebook Director Sees 'Billions' in Revenue in 5 Years
- A Goldman Trading Scandal?
- Accused Ex-Goldman Sachs Programmer Out on Bail
- Saudis Looking to UK Property?
- Chadwick: Recession and Scandals Pave the Way for Romney 2012
- The Threat of Ballooning Pensions
- Lehman CEO: Firm Deserved Bailout or 'Wind Down'
- Ryanair May Make Passengers Stand to Cut Costs
- Microsoft Warns of Serious Computer Security Hole
- China's BAIC Faces Tough Odds in Opel Bid
- G8 to Agree to Fight Protectionism, Boost Farm Aid
- In Blow to Housing, Risky Mortgage Losses Seen Rising
- EU to Unveil New Banking Reforms in October: Report
- Second Half: Wait For Pullbacks, Then Buy the Best
- Web Exclusive: Hot Tips From Top Money Manager
- Accused Ex-Goldman Sachs Programmer Out on Bail
- Used Video Game Sales Soar: So Who Wins?
- Discover Shares Fall on Word of Stock Offering
- March Lows Will Hold — So Buy Equities: Strategists
- Lacoste Runs Full Page Ad With Roddick Loss
- Brandt: Bing, The Little Search Engine That Couldn't
- 5-Star Manager's 5 Top Stocks
- Hey, What's Up Doc?
- Busch: Summertime Blues Hits Investors
- Chadwick: Recession and Scandals Pave the Way for Romney 2012
- Art Cashin: The S&P's 'Head and Shoulders' Number
- Michael Jackson: Death And Taxes
(For a story on the stem cell rules, click on ) July 6 (Reuters) - The U.S. National Institutes of Health released final rules on Monday governing federal funding of human embryonic stem cell research. Following are some facts about stem cells: * Stem cells are the body's master cells, the source of all cells and tissue, including brain, blood, heart, bones and muscles. * Embryonic stem cells come from days-old embryos and can produce any type of cell in the body. * Scientists generally harvest embryonic stem cells from embryos left over after in vitro fertilization attempts at fertility clinics. They can also be produced using cloning technology but the new U.S. rules allow for federal funding only of work on surplus IVF embryos. * Scientists hope to harness the transformational qualities of stem cells to treat a variety of diseases, including injuries, cancer and cystic fibrosis. * The issue is controversial because some people believe the destruction of any human embryo is wrong. * Several companies are pursuing stem cell research including Geron Corp.
which last week teamed up with General Electric Co to use stem cells to test new drugs for toxicity. * Other companies involved in stem cell research include Stemcells Inc., Advanced Cell Technology, NeuralStem, Aastrom Biosciences Inc., Reneuron Group Plc., Thermogenesis, Osiris Therapeutics Inc, Neostem Inc., Cytori Therapeutics Inc. , iZumi Bio Inc., and International Stem Cell Corporation. *U.S. legislation called the Dickey Amendment forbids the use of federal funds for the creation or destruction of human embryos for research, but new U.S. policy allows federally funded researchers to work with cells someone else had taken from an embryo. * The issue does not fall clearly along party lines and some conservative Republicans who oppose abortion have backed broader federal funding of embryonic stem cell research for years. * Britain, Belgium, Sweden, Canada and New Zealand encourage embryonic stem cell research. Austria, Lithuania and Poland have laws banning most human embryonic stem cell research. * Researchers have discovered how to make embryonic-like cells from ordinary cells, called induced pluripotent stem cells. Opponents of embryonic stem cell research say research can focus on this field, but most scientists agree that all approaches must be pursued. (Editing by David Storey) Keywords: STEMCELLS USA (Maggie.Fox@Reuters.com; +1 202 898 8492) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.








